Oncodesign Société Anonyme

ENXTPA:ALONC Stock Report

Market Cap: €99.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Oncodesign Société Anonyme Future Growth

Future criteria checks 5/6

Key information

101.2%

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth25.6%
Revenue growth rate14.7%
Future return on equity46.3%
Analyst coverage

Low

Last updatedn/a

Recent future growth updates

Recent updates

Need To Know: The Consensus Just Cut Its Oncodesign Société Anonyme (EPA:ALONC) Estimates For 2022

Apr 16
Need To Know: The Consensus Just Cut Its Oncodesign Société Anonyme (EPA:ALONC) Estimates For 2022

Calculating The Intrinsic Value Of Oncodesign Société Anonyme (EPA:ALONC)

Jun 08
Calculating The Intrinsic Value Of Oncodesign Société Anonyme (EPA:ALONC)

Are Oncodesign Société Anonyme (EPA:ALONC) Investors Paying Above The Intrinsic Value?

Feb 22
Are Oncodesign Société Anonyme (EPA:ALONC) Investors Paying Above The Intrinsic Value?

Earnings and Revenue Growth Forecasts

ENXTPA:ALONC - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202454108N/A1
12/31/20235581N/A2
12/31/202249-2-1N/A2
6/30/202233-6N/AN/AN/A
3/31/202232-3N/AN/AN/A
12/31/2021320-21N/A
9/30/2021331N/AN/AN/A
6/30/2021382-8-5N/A
3/31/2021382-11N/A
12/31/202034268N/A
9/30/2020362N/AN/AN/A
6/30/202038168N/A
3/31/202038124N/A
12/31/2019392-20N/A
9/30/2019361N/AN/AN/A
6/30/201934126N/A
3/31/201931-103N/A
12/31/201828-3-30N/A
9/30/201825-5N/AN/AN/A
6/30/201824-7-13-8N/A
3/31/201823-6-11-7N/A
12/31/201722-5-10-6N/A
9/30/201723-2-4-2N/A
6/30/201718113N/A
3/31/201715112N/A
12/31/201615101N/A
9/30/2016140N/AN/AN/A
6/30/2016140-2-1N/A
3/31/2016151N/A-1N/A
12/31/2015151N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALONC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.4%).

Earnings vs Market: ALONC is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ALONC is expected to become profitable in the next 3 years.

Revenue vs Market: ALONC's revenue (14.7% per year) is forecast to grow faster than the French market (5.1% per year).

High Growth Revenue: ALONC's revenue (14.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ALONC's Return on Equity is forecast to be very high in 3 years time (46.3%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.